Operating Metrics 營運指標
AbbVie Inc. (ABBV) Operating Metrics 營運指標
AbbVie Inc. ABBV 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- Immunology Portfolio Revenue
- $32,587M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
- Neuroscience Portfolio Revenue
- $11,905M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
- Oncology Portfolio Revenue
- $6,627M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
- Aesthetics Portfolio Revenue
- $4,947M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
- Skyrizi Revenue
- $19,702M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
- Rinvoq Revenue
- $9,202M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
- Humira Revenue
- $3,683M · 2026-06-30 來源：AbbVie Inc.、AbbVie Inc.、AbbVie Inc.、AbbVie Inc.
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Immunology Portfolio Revenue | $8,786M | $7,290M | $8,626M | $7,885M | $7,631M | $6,264M | $7,294M | $7,046M |
| Neuroscience Portfolio Revenue | $3,228M | $2,875M | $2,961M | $2,841M | $2,683M | $2,282M | $2,509M | $2,363M |
| Oncology Portfolio Revenue | $1,650M | $1,631M | $1,664M | $1,682M | $1,676M | $1,633M | $1,691M | $1,687M |
| Aesthetics Portfolio Revenue | $1,282M | $1,186M | $1,286M | $1,193M | $1,279M | $1,102M | $1,298M | $1,239M |
| Skyrizi Revenue | $5,505M | $4,483M | $5,006M | $4,708M | $4,423M | $3,425M | $3,778M | $3,205M |
| Rinvoq Revenue | $2,525M | $2,119M | $2,374M | $2,184M | $2,028M | $1,718M | $1,834M | $1,614M |
| Humira Revenue | $756M | $688M | $1,246M | $993M | $1,180M | $1,121M | $1,682M | $2,227M |
資料來源
- AbbVie Reports Second-Quarter 2026 Financial Results · AbbVie Inc. · 2026-07-31
- AbbVie Reports First-Quarter 2026 Financial Results · AbbVie Inc. · 2026-04-29
- AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results · AbbVie Inc. · 2026-02-04
- AbbVie Reports Third-Quarter 2025 Financial Results · AbbVie Inc. · 2025-10-31
- AbbVie Reports Second-Quarter 2025 Financial Results · AbbVie Inc. · 2025-07-31
- AbbVie Reports First-Quarter 2025 Financial Results · AbbVie Inc. · 2025-04-25
- AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results · AbbVie Inc. · 2025-01-31
- AbbVie Reports Third-Quarter 2024 Financial Results · AbbVie Inc. · 2024-10-30